Challenging Management of Neuroendocrine Tumor With Hepatic Metastasis and Carcinoid Heart Disease in a Child.

about

Challenging Management of Neuroendocrine Tumor With Hepatic Metastasis and Carcinoid Heart Disease in a Child.

Item

http://www.wikidata.org/entity/Q51366001

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Challenging Management of Neur ...... noid Heart Disease in a Child.

@en

Challenging Management of Neur ...... noid Heart Disease in a Child.

@nl

type

Item

label

Challenging Management of Neur ...... noid Heart Disease in a Child.

@en

Challenging Management of Neur ...... noid Heart Disease in a Child.

@nl

prefLabel

Challenging Management of Neur ...... noid Heart Disease in a Child.

@en

Challenging Management of Neur ...... noid Heart Disease in a Child.

@nl

P1476

Challenging Management of Neur ...... noid Heart Disease in a Child.

@en

P2093

Ceyhun Bozkurt

http://www.w3.org/2001/XMLSchema#string

Elgin Ozkan

http://www.w3.org/2001/XMLSchema#string

Emin Cakmakci

http://www.w3.org/2001/XMLSchema#string

Gurses Sahin

http://www.w3.org/2001/XMLSchema#string

Hikmet Gulsah Tanyildiz

http://www.w3.org/2001/XMLSchema#string

Sait Aslamacı

http://www.w3.org/2001/XMLSchema#string

Senem Ozgur

http://www.w3.org/2001/XMLSchema#string

Sule Yesil

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting the mTOR signaling pathway in neuroendocrine tumors

The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems

Salvage therapy with (177)Lu-octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumors.

177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.

Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors.

Neuroendocrine tumors in children and young adults: rare or not so rare.

Clinical review: Current scientific rationale for the use of somatostatin analogs and mTOR inhibitors in neuroendocrine tumor therapy.

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival.

Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study

P304

1499-1500

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.25993

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27092713

http://www.w3.org/2001/XMLSchema#string